BlackRock’s OptiNose OPTN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-47,988
| Closed | -$440K | – | 5561 |
|
|
2025
Q1 | $440K | Sell |
47,988
-7,880
| -14% | -$49.5K | ﹤0.01% | 4428 |
|
|
2024
Q4 | $373K | Buy |
55,868
+3,976
| +8% | +$35K | ﹤0.01% | 4497 |
|
|
2024
Q3 | $522K | Sell |
51,892
-299,716
| -85% | -$4.37M | ﹤0.01% | 4316 |
|
|
2024
Q2 | $5.49M | Buy |
351,608
+66,054
| +23% | +$1.11M | ﹤0.01% | 3656 |
|
|
2024
Q1 | $6.25M | Sell |
285,554
-8,063
| -3% | -$179K | ﹤0.01% | 3585 |
|
|
2023
Q4 | $5.68M | Buy |
293,617
+15,092
| +5% | +$275K | ﹤0.01% | 3642 |
|
|
2023
Q3 | $5.14M | Buy |
278,525
+18,308
| +7% | +$330K | ﹤0.01% | 3651 |
|
|
2023
Q2 | $4.8M | Buy |
260,217
+216,415
| +494% | +$5.12M | ﹤0.01% | 3737 |
|
|
2023
Q1 | $1.27M | Buy |
43,802
+1,961
| +5% | +$52.2K | ﹤0.01% | 4249 |
|
|
2022
Q4 | $1.16M | Sell |
41,841
-2,155
| -5% | -$81.8K | ﹤0.01% | 4360 |
|
|
2022
Q3 | $2.42M | Sell |
43,996
-5,423
| -11% | -$298K | ﹤0.01% | 4091 |
|
|
2022
Q2 | $2.71M | Sell |
49,419
-2,074
| -4% | -$76.3K | ﹤0.01% | 4106 |
|
|
2022
Q1 | $1.91M | Buy |
51,493
+1,478
| +3% | +$52.8K | ﹤0.01% | 4417 |
|
|
2021
Q4 | $1.22M | Buy |
50,015
+1,339
| +3% | +$44.8K | ﹤0.01% | 4605 |
|
|
2021
Q3 | $2.19M | Buy |
48,676
+7,855
| +19% | +$330K | ﹤0.01% | 4284 |
|
|
2021
Q2 | $1.9M | Sell |
40,821
-122,834
| -75% | -$6.27M | ﹤0.01% | 4292 |
|
|
2021
Q1 | $9.06M | Buy |
163,655
+7,245
| +5% | +$441K | ﹤0.01% | 3629 |
|
|
2020
Q4 | $9.71M | Sell |
156,410
-15,605
| -9% | -$956K | ﹤0.01% | 3377 |
|
|
2020
Q3 | $10.1M | Buy |
172,015
+4,607
| +3% | +$341K | ﹤0.01% | 3214 |
|
|
2020
Q2 | $18.7M | Buy |
167,408
+19,541
| +13% | +$1.39M | ﹤0.01% | 2828 |
|
|
2020
Q1 | $9.96M | Sell |
147,867
-810
| -0.5% | -$81.6K | ﹤0.01% | 2993 |
|
|
2019
Q4 | $20.6M | Buy |
148,677
+14,996
| +11% | +$1.94M | ﹤0.01% | 2864 |
|
|
2019
Q3 | $14M | Buy |
133,681
+5,753
| +4% | +$574K | ﹤0.01% | 3015 |
|
|
2019
Q2 | $13.6M | Buy |
127,928
+17,578
| +16% | +$2.32M | ﹤0.01% | 3064 |
|
|
2019
Q1 | $17M | Sell |
110,350
-10,994
| -9% | -$1.27M | ﹤0.01% | 2831 |
|
|
2018
Q4 | $11.3M | Buy |
121,344
+49,557
| +69% | +$7.08M | ﹤0.01% | 3017 |
|
|
2018
Q3 | $13.4M | Buy |
71,787
+5,303
| +8% | +$1.51M | ﹤0.01% | 3085 |
|
|
2018
Q2 | $27.9M | Buy |
66,484
+51,235
| +336% | +$17.3M | ﹤0.01% | 2674 |
|
|
2018
Q1 | $4.58M | Sell |
15,249
-102
| -0.7% | -$28.3K | ﹤0.01% | 3451 |
|
|
2017
Q4 | $4.35M | Buy |
+15,351
| New | +$4.32M | ﹤0.01% | 3490 |
|
BlackRock's OPTN Position: Q2 2025 in Review
BlackRock sold out of OptiNose (OPTN) in Q2 2025, closing a stake of 47,988 shares — an estimated $440K sold.
BlackRock first reported a position in OPTN in Q4 2017 and held it in 30 quarters. The position peaked at $27.9M in Q2 2018. 0 funds tracked by Wall St. Rank hold OPTN as of Q2 2025.
- BlackRock reported no remaining OptiNose position as of Q2 2025 after selling out during the quarter.
- BlackRock sold 47,988 OptiNose shares in Q2 2025, an estimated $440K.
- BlackRock first reported a position in OptiNose in Q4 2017 and held it in 30 quarters.
- BlackRock's OptiNose position peaked at $27.9M in Q2 2018.
- 0 funds tracked by Wall St. Rank held OptiNose as of Q2 2025.
Based on BlackRock's 13F filing for Q2 2025, filed 12 Aug 2025.